WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005030774) HCV INHIBITORS AND METHODS OF USING THEM
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/030774    International Application No.:    PCT/US2004/031705
Publication Date: 07.04.2005 International Filing Date: 27.09.2004
IPC:
A61K 31/4709 (2006.01), A61K 31/4745 (2006.01), A61P 31/12 (2006.01), C07D 215/54 (2006.01), C07D 471/04 (2006.01), C07D 471/14 (2006.01), C07D 491/14 (2006.01)
Applicants: RIGEL PHARMACEUTICALS, INC. [US/US]; 240 East Grand Avenue, South San Francisco, CA 94080 (US) (For All Designated States Except US).
THOTA, Sambaiah [IN/US]; (US) (For US Only).
ARGADE, Ankush [IN/US]; (US) (For US Only).
SINGH, Rajinder [GB/US]; (US) (For US Only).
LU, Henry, H. [US/US]; (US) (For US Only).
HUANG, Peiyong [CN/US]; (US) (For US Only)
Inventors: THOTA, Sambaiah; (US).
ARGADE, Ankush; (US).
SINGH, Rajinder; (US).
LU, Henry, H.; (US).
HUANG, Peiyong; (US)
Agent: GREENFIELD, Michael, S.; McDonnell Boehnen Hulbert & Berghoff LLP, 300 South Wacker Drive, Suite 3100, Chicago, IL 60606 (US)
Priority Data:
60/506,556 26.09.2003 US
60/576,536 03.06.2004 US
Title (EN) HCV INHIBITORS AND METHODS OF USING THEM
(FR) INHIBITEURS DU VHC ET METHODES D'UTILISATION DE CES INHIBITEURS
Abstract: front page image
(EN)The present invention comprises tetrazoloquinoline-compounds that are inhibitors of HCV. Compositions comprising the compounds in combination with a pharmaceutically acceptable carrier are also disclosed, as are methods of using the compounds and compositions to inhibit HCV infection of a cell, particular in the form of treating HCV infection in a mammal.
(FR)La présente invention concerne des composés tétrazoloquinoline qui constituent des inhibiteurs du virus de l'hépatite C (VHC). Cette invention concerne également des compositions renfermant ces composés combinés à un excipient pharmaceutiquement acceptable ainsi que des méthodes d'utilisation de ces composés et compositions pour inhiber une infection par le VHC d'une cellule et en particulier des méthodes de traitement d'une infection par le VHC chez un mammifère.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)